5:33 AM
 | 
Aug 08, 2018
 |  BC Extra  |  Financial News

SQZ raises $72M series C

Cell therapy company SQZ Biotechnologies Co. (Watertown, Mass.) raised $72 million in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life and Viva Ventures Biotech Group participated, as did existing investors Bridger Healthcare Partners,...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >